Inovio Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Inovio Pharmaceuticals has a total shareholder equity of $94.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $129.1M and $34.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$105.61m |
Equity | US$94.44m |
Total liabilities | US$34.67m |
Total assets | US$129.11m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0A43's short term assets ($111.7M) exceed its short term liabilities ($23.4M).
Long Term Liabilities: 0A43's short term assets ($111.7M) exceed its long term liabilities ($11.3M).
Debt to Equity History and Analysis
Debt Level: 0A43 is debt free.
Reducing Debt: 0A43 has no debt compared to 5 years ago when its debt to equity ratio was 74.8%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0A43 has sufficient cash runway for 11 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: 0A43 is forecast to have sufficient cash runway for 10 months based on free cash flow estimates, but has since raised additional capital.